Esprint Investigación · Mar 9, 2026
Cellular senescence: biological mechanisms and therapeutic advances in aging-related diseases
By Ramos GSM
Cellular senescence is a process characterized by irreversible cell cycle arrest and secretion of the senescence-associated secretory phenotype (SASP), which plays a dual role in the physiology and pathology of aging. Under physiological conditions, it contributes to tissue repair and the maintenance of homeostasis; however, its progressive accumulation favors cellular and tissue dysfunction, promoting the development of age-related diseases, such as cardiovascular, neurodegenerative, metabolic, renal, and pulmonary diseases and various types of cancer. The objective of the present study is to analyze and synthesize current evidence on this biological duality and examine the therapeutic potential of emerging senotherapeutic strategies. Among these, senolytics selectively eliminate senescent cells through the intermittently administered induction of apoptosis, whereas senomorphics, such as metformin and rapamycin, modulate the effects of the SASP without inducing cell death. Likewise, immunotherapy represents an innovative approach by enhancing the immune system's ability to recognize and eliminate senescent cells through strategies such as CAR-T cells, CAR-NK cells, targeted antibodies, and senolytic vaccines. Together, these advances position cellular senescence as a key therapeutic target for the prevention and treatment of chronic diseases associated with aging.